Cargando…
The road for survival improvement of cystic fibrosis patients in Arab countries
Cystic fibrosis (CF) is a lethal, monogenic disorder that affects multiple organ systems of the body. The incidence has been described before in the Middle East to be 1 in 2000 to 1 in 5800 live births, and the median survival was estimated to be from 10 to 20 years of age. The present article attem...
Autores principales: | Banjar, Hanaa, Angyalosi, Gerhild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372404/ https://www.ncbi.nlm.nih.gov/pubmed/30805437 http://dx.doi.org/10.1016/j.ijpam.2015.05.006 |
Ejemplares similares
-
Cystic Fibrosis Gene Therapy in the UK and Elsewhere
por: Griesenbach, Uta, et al.
Publicado: (2015) -
Update on the management of vitamins and minerals in cystic fibrosis
por: Sankararaman, Senthilkumar, et al.
Publicado: (2022) -
Correlation of Gut Microbiota, Vitamin D Status, and Pulmonary Function Tests in Children With Cystic Fibrosis
por: Albedewi, Hadeel, et al.
Publicado: (2022) -
The first report on immunoglobulins A, E, G and M levels in cystic fibrosis patients in Saudi Arabia
por: Alothaid, Hani, et al.
Publicado: (2020) -
The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review
por: Banjar, Hanaa, et al.
Publicado: (2022)